Background/purpose: Cell adhesion molecule 1 (CADM1) functions as a tumor suppressor and has been identified to be frequently inactivated in breast cancer, and closely associated with patients' poor prognosis and advanced TNM stage. However, the mechanisms underlying CADM1 in breast cancer progression remains incompletely clear. miR-155, a predicted modulator of CADM1 was reported to be overexpressed in breast cancer, and its high expression level was closely related to the malignant progression of breast cancer. The present study aimed to explore whether miR-155-3p could modulate CADM1 expression and then involved in the progression of breast cancer.
Methods: The expression patterns of miR-155-3p in breast cancer tissues and cell lines were determined by RT-PCR technology. The relationship between CADM1 and miR-155-3p were determined by the luciferase gene reporter and Western Blot (WB) assays. Cell proliferation, apoptosis rates and tumorigenesis were determined by CCK-8, flow cytometry and in vivo xenotransplanation experiments, respectively.
Results: miR-155-3p was up-regulated in breast cancer tissues and cells when compared to the adjacent normal tissues and normal breast MCF 10A cells. The mRNA and protein levels of CADM1 showed opposite expression patterns to that of miR-155-3p expression detected, and miR-155-3p could negatively regulate CADM1 expression in breast cancer MCF-7 cells. Moreover, gain-of function assay showed that overexpression of miR-155-3p promoted cell proliferation, tumorigenesis and repressed cell apoptosis, but these effects were all significantly impaired when the cells were simultaneously transfected with OE-CADM1, the overexpressing vector of CADM1.
Conclusion: This study revealed that miR-155-3p could accelerate the progression of breast cancer via down-regulation of CADM1 expression.
Keywords: CADM1; breast cancer; miR-155-3p.
© 2019 Zhang et al.
Conflict of interest statement
The authors have declared that no competing interest exists in this work.
Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.Cell Physiol Biochem. 2018;50(3):987-1004. doi: 10.1159/000494482. Epub 2018 Oct 24. Cell Physiol Biochem. 2018. PMID: 30355927
miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1.Oncol Lett. 2018 Aug;16(2):2620-2628. doi: 10.3892/ol.2018.8927. Epub 2018 Jun 8. Oncol Lett. 2018. PMID: 30013657 Free PMC article.
MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.J BUON. 2018 Sep-Oct;23(5):1309-1315. J BUON. 2018. PMID: 30570852
MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.Breast Cancer. 2018 Nov;25(6):742-752. doi: 10.1007/s12282-018-0881-5. Epub 2018 Jun 27. Breast Cancer. 2018. PMID: 29951881
MicroRNA-9 and breast cancer.Biomed Pharmacother. 2020 Feb;122:109687. doi: 10.1016/j.biopha.2019.109687. Epub 2019 Dec 30. Biomed Pharmacother. 2020. PMID: 31918267 Review.
Cited by 1 article
miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma.Onco Targets Ther. 2019 Nov 29;12:10441-10453. doi: 10.2147/OTT.S224325. eCollection 2019. Onco Targets Ther. 2019. PMID: 31819525 Free PMC article.